Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Ginsenoside Rk1

SKU: orb1220890

Description

Ginsenoside Rk1 is a component created by processing the ginseng plant at high temperatures. Ginsenoside Rk1 has an anti-inflammatory effect suppresses the activation of Jak2/Stat3 signaling pathway and NF-κB. It also has an anti-tumor effect.

Images & Validation

Key Properties

CAS Number494753-69-4
MW767.01
Purity>98% (HPLC)
FormulaC42H70O12
SMILES[H][C@@]12[C@H](CC[C@@]1(C)[C@]1(C)CC[C@@]3([H])C(C)(C)[C@H](CC[C@]3(C)[C@@]1([H])C[C@H]2O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=C)CC\C=C(/C)C
TargetOthers
SolubilityDMSO: 90 mg/mL (117.34 mM)

Bioactivity

In Vitro
Ginsenoside Rk1 (0-40 μM; 6 hours) inhibits MCP-1 and TNF-α mRNA induced by lipopolysaccharide (LPS), expression of IL-1β is inhibited at 40 μM. Ginsenoside Rk1 (0-40 μM; 24 hours) inhibits phosphorylation of JAK2 and STAT3 (Tyr705 and Ser727) in LPS-induced RAW264.7 cells in a dose-dependent manner. Ginsenoside Rk1 (0-160 μM; 48 hours) results in cell viability significant decrease 75.52 ± 2.51% (40 μM), 52.72 ± 2.54% (80 μM), 17.41 ± 2.94% (120 μM)and 12.63 ± 3.24% (160 μM) compared with control. Ginsenoside Rk1 (0-120 μM; 24 hours) increases G0/G1 phase proportion accompanied with S and G2/M phase proportion decrease in MDA-MB-231 cells. Ginsenoside Rk1 (0-120 μM; 24 hours) promotes the percentage of apoptotic cells in a dose-dependent manner, exhibits to reduction of cell number with nucleus fragmentation, condensation and apoptotic body formation. RT-PCR Cell line: RAW264.7 cells Concentration: 10 μM, 20 μM, 40 μM. Incubation time: 6 hours. Result: Inhibited JAK2-dependent STAT3 activation in LPS-activated RAW264.7 cells. Western blot analysis. Cell line: RAW264.7 cells Concentration: 10 μM, 20 μM, 40 μM. Incubation time: 6 hours. Result: Inhibited JAK2-dependent STAT3 activation in LPS-activated RAW264.7 cells Cell Viability Assay Cell line: MDA-MB-231 cells. Concentration: 0 μM, 40 μM, 80 μM, 120 μM. Incubation time: 48 hours. Result: Inhibited MDA-MB-231 cells proliferation in a dose- and time-dependent manner. Cell Cycle Analysis Cell line: MDA-MB-231 cells. Concentration: 0 μM, 40 μM, 80 μM, 120 μM. Incubation time: 24 hours. Result: Induced G0/G1 phase arrest. Apoptosis Analysis Cell line: MDA-MB-231 cells. Concentration: 0 μM, 40 μM, 80 μM, 120 μM. Incubation time: 24 hours. Result: Induced apoptosis in MDA-MB-231 cells.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Ginsenoside Rk1 [orb1302317]

    98.30% (May vary between batches)

    494753-69-4

    767.00

    C42H70O12

    5 mg
  • Ginsenoside Rk2 [orb2654599]

    >98% (HPLC)

    364779-14-6

    604.9

    C36H60O7

    100 mg, 50 mg, 5 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Ginsenoside Rk1 (orb1220890)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%